AnalysisHealthOctober 19, 2026

STAT examines whether Isomorphic Labs can deliver on AlphaFold's drugmaking promise

Read original source →statnews.com

Thrive Capital spent 18 months courting Isomorphic Labs, the Alphabet AI offshoot built on the AlphaFold protein-modeling tool that underpinned a Nobel Prize in chemistry. The question now is whether Isomorphic can turn that technology into an engine for new medicines.

1 source

More stories today

Open the live feed